Mangalam Drugs and Organics Ltd: Financial Statements & Historical Data

COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 9 October 2026, 9:03 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price31.1₹ per share

Reported P/ENot availableTimes

Book value per share65.3₹ per share

Reported ROCE14.0 %%

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Financial changes explained

Automatically calculated historical comparisons. Amounts are in ₹ crore unless stated otherwise. These summaries describe reported figures and do not rate or recommend the shares.

Reporting coverage: Quarterly: Jun 2026 · Annual: Mar 2026 · Cash flow: Mar 2026 · Balance sheet: Mar 2026.

Quarterly revenue change

Quarterly revenue was ₹57.12 crore in Jun 2026, compared with ₹57.21 crore in Jun 2025. The change was a decrease of ₹0.09 crore. Year-on-year change: -0.2%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: standalone. Period: 2025-06 to 2026-06.

View the financial table · Data source

Quarterly net result change

Quarterly net result was −₹7.55 crore in Jun 2026, compared with −₹13.73 crore in Jun 2025. The change was an increase of ₹6.18 crore. A percentage growth figure is omitted because a comparison involves a loss, negative amount or zero base.

Calculation and source

Absolute change = later amount − earlier amount.

Basis: standalone. Period: 2025-06 to 2026-06.

View the financial table · Data source

Annual revenue change

Annual revenue was ₹232.00 crore in Mar 2026, compared with ₹318.00 crore in Mar 2025. The change was a decrease of ₹86.00 crore. Year-on-year change: -27.0%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: standalone. Period: 2025-03 to 2026-03.

View the financial table · Data source

Annual net result change

Annual net result was −₹44.00 crore in Mar 2026, compared with ₹7.00 crore in Mar 2025. The change was a decrease of ₹51.00 crore. A percentage growth figure is omitted because a comparison involves a loss, negative amount or zero base.

Calculation and source

Absolute change = later amount − earlier amount.

Basis: standalone. Period: 2025-03 to 2026-03.

View the financial table · Data source

Quarterly net profit margin

Calculated net profit margin moved from -24.00% in Jun 2025 to -13.22% in Jun 2026: 10.78 percentage points higher.

Calculation and source

Margin = net profit ÷ revenue × 100. Margin change is measured in percentage points; rounded source figures can affect the result.

Basis: standalone. Period: 2025-06 to 2026-06.

View the financial table · Data source

Eight-quarter revenue comparison

Revenue across the four quarters ending Jun 2026 totalled ₹232.33 crore, compared with ₹298.64 crore across the preceding four quarters. The change was -22.2%.

Calculation and source

Sum four consecutive quarters and compare with the preceding four non-overlapping quarters. All eight observations must exist.

Basis: standalone. Period: 2024-09 to 2026-06.

View the financial table · Data source

Profit and operating cash flow

For Mar 2026, operating cash flow was ₹4.00 crore and net profit was −₹44.00 crore. The ratio is omitted because net profit is zero or negative.

Calculation and source

These are different accounting measures. The ratio, when shown, uses the same reporting period and accounting basis; it is not an earnings-quality rating.

Basis: standalone. Period: 2026-03.

View the financial table · Data source

Net profit history

Net profit was positive in 3 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: standalone. Period: 2022-03 to 2026-03.

View the financial table · Data source

Operating cash flow history

Operating cash flow was positive in 5 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: standalone. Period: 2022-03 to 2026-03.

View the financial table · Data source

Reported borrowings change

Reported borrowings was ₹105.00 crore in Mar 2026, compared with ₹96.00 crore in Mar 2025. The change was an increase of ₹9.00 crore. Year-on-year change: +9.4%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: standalone. Period: 2025-03 to 2026-03.

View the financial table · Data source

Promoters ownership share

Reported Promoters ownership moved from 35.65% in Mar 2026 to 35.65% in Jun 2026, a change of 0.00 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

FIIs ownership share

Reported FIIs ownership moved from 0.32% in Mar 2026 to 0.11% in Jun 2026, a change of -0.21 percentage points.

Calculation and source

Later ownership percentage − earlier percentage. Ownership proportions do not establish purchases or sales; changes in share capital can also affect them.

Basis: Issuer ownership; separately refreshed. Period: 2026-03 to 2026-06.

View the financial table · Data source

Summary generated: 10 Oct 2026, 19:57 IST. Figures may be rounded, delayed or restated. Comparisons follow the source’s annual and quarterly classifications; changes in reporting duration or accounting policies can limit comparability. Check original filings. No cause for a change is inferred from arithmetic alone.

Stored market and accounting figures

Price record: 9 October 2026, 9:03 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	49.2 Cr.
Current Price	31.1
High / Low	73.0/22.7
Stock P/E	Not available
Book Value	65.3
Dividend Yield	0.00 %
ROCE	14.0 %
ROE	34.8 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Mangalam Drugs and Organics Ltd	49.2 Cr.	31.1	73.0/22.7		65.3	0.00 %	14.0 %	34.8 %	10.0
Biofil Chemicals & Pharmaceuticals Ltd	49.1 Cr.	30.2	46.8/25.6	102	13.2	0.00 %	2.97 %	2.83 %	10.0
ANG Lifesciences India Ltd	48.4 Cr.	37.1	49.7/17.6		47.6	0.00 %	1.14 %	7.38 %	10.0
Murae Organisor Ltd	38.8 Cr.	0.19	0.44/0.19	2.56	1.02	0.00 %	4.20 %	5.69 %	1.00
Bharat Immunological & Biological Corporation Ltd	38.2 Cr.	8.84	22.6/7.11		18.2	0.00 %	9.27 %	17.7 %	10.0
Industry Average	17,127.26 Cr	1,216.62		53.25	211.24	0.40%	26.16%	16.59%	6.06

All Competitor Stocks of Mangalam Drugs and Organics Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	87.46	81.56	97.34	102.24	76.53	79.94	88.71	72.78	57.21	49.54	58.38	67.29	57.12
Expenses	90.94	79.37	90.36	90.54	68.34	71.25	79.94	62.88	61.86	52.37	59.96	72.65	56.22
Operating Profit	-3.48	2.19	6.98	11.70	8.19	8.69	8.77	9.90	-4.65	-2.83	-1.58	-5.36	0.90
OPM %	-3.98%	2.69%	7.17%	11.44%	10.70%	10.87%	9.89%	13.60%	-8.13%	-5.71%	-2.71%	-7.97%	1.58%
Other Income	0.02	0.03	0.00	0.05	0.02	0.14	0.13	0.47	0.14	0.03	0.22	0.09	0.11
Interest	3.41	3.24	3.31	3.95	3.75	3.67	3.49	4.03	4.04	5.03	4.05	3.08	3.68
Depreciation	3.42	3.73	3.62	3.86	3.87	3.97	3.93	4.61	4.38	4.53	4.37	4.56	3.99
Profit before tax	-10.29	-4.75	0.05	3.94	0.59	1.19	1.48	1.73	-12.93	-12.36	-9.78	-12.91	-6.66
Tax %	-7.29%	-25.05%	-920.00%	9.90%	-355.93%	-125.21%	5.41%	90.75%	6.19%	-41.42%	0.00%	1.16%	13.36%
Net Profit	-9.54	-3.56	0.50	3.55	2.68	2.69	1.40	0.15	-13.73	-7.25	-9.78	-13.06	-7.55
EPS in Rs	-6.03	-2.25	0.32	2.24	1.69	1.70	0.88	0.09	-8.67	-4.58	-6.18	-8.25	-4.77

Last Updated: October 8, 2026, 4:14 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 8, 2026, 4:14 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	123	221	295	299	269	228	282	380	451	372	369	318	232	232
Expenses	113	200	257	252	222	218	259	327	402	347	351	282	247	241
Operating Profit	10	20	38	47	47	10	24	53	49	26	17	36	-15	-9
OPM %	8%	9%	13%	16%	17%	4.3%	8%	14%	11%	7%	4.7%	11%	-6%	-3.8%
Other Income	0	0	0	-0	1	0	1	5	0	0	0	0	1	0
Interest	10	10	9	10	12	9	10	9	11	13	14	15	16	16
Depreciation	4	4	4	5	7	7	8	9	10	11	15	16	18	17
Profit before tax	-4	6	24	31	29	-6	6	40	28	2	-11	5	-48	-42
Tax %	-22%	-2%	33%	29%	32%	40%	-32%	29%	29%	43%	-18%	-39%	-9%
Net Profit	-3	6	16	22	20	-8	8	28	20	1	-9	7	-44	-38
EPS in Rs	-2.31	4.66	11.15	14.08	12.57	-5.07	5.21	17.67	12.42	0.80	-5.72	4.37	-27.68	-23.78
Dividend Payout %	0%	0%	0%	0%	4%	0%	0%	0%	0%	0%	0%	0%	0%

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	300.00%	166.67%	37.50%	-9.09%	-140.00%	200.00%	250.00%	-28.57%	-95.00%	-1000.00%	177.78%	-728.57%
Change in YoY Net Profit Growth (%)	0.00%	-133.33%	-129.17%	-46.59%	-130.91%	340.00%	50.00%	-278.57%	-66.43%	-905.00%	1177.78%	-906.35%

Mangalam Drugs and Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

No data available for the compounded sales growth chart.

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 8, 2026, 4:14 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	14	16	16	16	16	16	16	16	16	16	16
Reserves	16	47	70	88	80	88	115	135	136	127	133	87
Borrowings	78	60	66	69	65	52	70	88	89	107	96	105
Other Liabilities	63	38	38	54	50	75	64	90	117	108	114	99
Total Liabilities	170	160	190	227	211	231	264	328	358	357	359	308
Fixed Assets	53	54	93	102	103	101	118	135	142	147	156	152
CWIP	0	5	0	0	0	1	6	6	9	8	3	0
Investments	0	0	2	0	0	0	0	0	0	0	0	0
Other Assets	117	100	95	125	107	128	140	188	206	202	201	156
Total Assets	170	160	190	227	211	231	264	328	358	357	359	308

FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	14	22	43	25	22	31	28	26	38	12	43	4
Cash from Investing Activity +	-4	-11	-39	-16	-9	-7	-31	-27	-22	-18	-19	-12
Cash from Financing Activity +	-10	-11	-3	-9	-11	-23	3	3	-17	6	-22	6
Net Cash Flow	1	-0	0	-0	1	0	-1	1	-1	-0	2	-2
Free Cash Flow	10	11	3	9	12	24	-4	-2	16	-6	23	-8
CFO/OP	69%	68%	107%	66%	223%	129%	69%	70%	148%	71%	119%	-30%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	10.00	11.00	3.00	9.00	12.00	24.00	-4.00	-2.00	16.00	-6.00	23.00	-8.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	88	73	37	45	61	28	52	52	38	46	28	45
Inventory Days	170	134	85	69	132	175	121	85	139	200	185	303
Days Payable	97	128	37	38	82	77	106	63	65	139	124	199
Cash Conversion Cycle	161	79	85	75	111	126	67	74	112	107	88	148
Working Capital Days	29	26	32	19	31	21	10	23	43	38	18	13
ROCE %	6%	16%	29%	31%	25%	2%	11%	27%	18%	6%	1%	8%

FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	50.31%	50.31%	50.31%	50.31%	50.30%	50.30%	50.30%	50.30%	50.30%	35.64%	35.65%	35.65%
FIIs	0.10%	0.10%	0.26%	0.21%	0.11%	0.11%	0.47%	0.53%	0.11%	0.13%	0.32%	0.11%
Public	49.59%	49.59%	49.42%	49.47%	49.58%	49.58%	49.23%	49.16%	49.57%	64.22%	64.03%	64.24%
No. of Shareholders	17,978	18,610	19,173	19,312	19,508	19,679	19,697	19,728	19,881	21,227	25,140	24,465

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24
FaceValue	10.00	10.00
Basic EPS (Rs.)	4.25	-5.73
Diluted EPS (Rs.)	4.25	-5.73
Cash EPS (Rs.)	14.74	3.52
Book Value[Excl.RevalReserv]/Share (Rs.)	94.12	85.79
Book Value[Incl.RevalReserv]/Share (Rs.)	94.12	85.79
Revenue From Operations / Share (Rs.)	201.05	232.87
PBDIT / Share (Rs.)	22.95	11.05
PBIT / Share (Rs.)	12.46	1.80
PBT / Share (Rs.)	3.02	-7.00
Net Profit / Share (Rs.)	4.25	-5.73
NP After MI And SOA / Share (Rs.)	4.25	-5.73
PBDIT Margin (%)	11.41	4.74
PBIT Margin (%)	6.19	0.77
PBT Margin (%)	1.50	-3.00
Net Profit Margin (%)	2.11	-2.46
NP After MI And SOA Margin (%)	2.11	-2.46
Return on Networth / Equity (%)	4.51	-6.68
Return on Capital Employeed (%)	11.27	1.67
Return On Assets (%)	1.83	-2.71
Long Term Debt / Equity (X)	0.06	0.09
Total Debt / Equity (X)	0.54	0.64
Asset Turnover Ratio (%)	0.90	0.00
Current Ratio (X)	1.04	1.07
Quick Ratio (X)	0.31	0.31
Inventory Turnover Ratio (X)	2.43	0.00
Interest Coverage Ratio (X)	2.43	1.26
Interest Coverage Ratio (Post Tax) (X)	1.45	0.34
Enterprise Value (Cr.)	196.06	233.41
EV / Net Operating Revenue (X)	0.61	0.63
EV / EBITDA (X)	5.40	13.34
MarketCap / Net Operating Revenue (X)	0.36	0.39
Price / BV (X)	0.78	1.08
Price / Net Operating Revenue (X)	0.36	0.39
EarningsYield	0.05	-0.06